Our research focuses on these two important features of lipid metabolism changes and high expression of HIF-2α in renal cancer, investigating the intersection of these processes, we aim to expand the understanding of HIF-2α-mediated lipid reprogramming and develop new strategies for the treatment of ccRCC. Here, EPAS1 is linked to renal carcinoma.